Read + Share
Amedeo Smart
Independent Medical Education
Sledge GWJ, Xiu J, Solzak JP, Ribeiro J, et al. Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis. Breast Cancer Res 2025;27:144.PMID: 40790607
Email
LinkedIn
Privacy Policy